Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
基本信息
- 批准号:10670318
- 负责人:
- 金额:$ 652.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskArchivesBiological MarkersBlood VesselsBostonBrainChronicClinicalCognitiveCohort StudiesCommunitiesComplementConsensusDataData SetDementiaDetectionDiagnosisDigital biomarkerDiseaseEarly DiagnosisElderlyExclusionFamilyFinancial costFramingham Heart StudyFutureGenerationsGenesGeneticGenetic Predisposition to DiseaseGoalsImageImpaired cognitionInflammationInflammatoryInfrastructureLeadershipLife StyleLinkMRI ScansMagnetic Resonance ImagingMeasuresMonitorNeurogliaNeurologicNeuropsychological TestsNeuropsychologyPaperParentsParticipantPathogenesisPathway interactionsPeripheralPersonsPhenotypePilot ProjectsPlayProteinsPublishingQualifyingResearchResearch PersonnelResourcesRiskRisk FactorsRoleSpousesStructureSymptomsUniversitiesWritingaging brainbrain healthbrain magnetic resonance imagingcare costscentral databasecognitive changecohortcomorbiditydata resourcedata sharingdementia riskdigitaldisorder preventionearly detection biomarkersgenetic analysisgenetic associationgenome-widehealth dataimprovedinnovationlifestyle datalongitudinal analysismembermiddle agemulti-ethnicneuropathologynew therapeutic targetnoveloffspringorganizational structurepre-clinicalprogramsresearch studyresilienceresponsesocietal coststargeted treatmenttrait
项目摘要
Since 1976, the Framingham Heart Study (FHS) has surveilled participants for incident dementia, initially, in the
Generation 1 participants, starting 1979 in the Generation 2 cohorts and in 1994 with the smaller multi-ethnic
Omni Generation 1 cohort. As the oldest of the Generation 3 and Omni Generation 2 move into the age of
dementia risk, we extended surveillance to these two younger cohorts. Baseline and repeat neuropsychological
(NP) assessments and brain magnetic resonance imaging (MRI) scans have been conducted since 1999 on the
Gen 1, Gen 2 and OmniGen 2 cohorts and since 2008 with the younger cohorts. Importantly, over nearly 7
decades, FHS has collected many co- morbid features linked to future risk of late life cognitive decline and
dementia across these cohorts when they were early to middle age. Complementing the health and lifestyle data
is the availability of genetic and peripheral biomarker data. Further, beginning in 2005, digital capture of spoken
responses was added to NP testing. This was extended to written responses in 2011, allowing quantification of
spoken and written responses at levels of granularity that can detect preclinical cognitive changes that traditional
NP test scores cannot measure. Previously, we have capitalized on the multi-generation uniqueness using
genome-wide approaches to discern novel genetic associations for AD risk and AD-related traits that were not
identified in datasets up to 20 times larger. The primary goal of this FHS Brain Aging Program (FHS-BAP) is
to continue dementia surveillance, extend longitudinal characterization of cognitive phenotypes and brain
structure, bring added resources to the brain donation program including neuropathological examination, in the
FHS cohorts in order to identify new and expand on known AD-related genetic and other risk factors and
biomarkers and to pursue innovative research about the vascular and inflammatory basis of AD. Another central
objective of FHS-BAP is to facilitate more widespread sharing of this extraordinary AD data resource with the
broader scientific community. Under a new organizational structure, Administrative, Clinical, Neuropathology and
Data cores will provide a formal management and infrastructure to continue incident dementia surveillance, NP
and MRI assessments of surviving participants of all FHS cohorts, and perform neuropathological examination
of brains obtained through the FHS brain donation program. The FHS-BAP will feature three inter-related projects
that have a focus on vascular and inflammatory contributors to AD. One project will identify factors that are
associated with AD risk and resilience using longitudinal analyses of FHS data including genetic, various `omic
genetic, clinical, imaging, lifestyle and other traits. A second project will investigate the link between AD genetic
vulnerabilities and chronic peripheral inflammation. A third project will determine genetic and protein alterations
of complement-related genes and glial cell phenotypes that modulate cognitive trajectories and
neuropathological profiles. Finally, this program will promote using FHS-BAP data, especially by early-stage and
non-AD investigators through a pilot projects program and through enhanced and proactive data sharing efforts.
自1976年以来,弗雷明汉心脏研究(FHS)一直在监测参与者发生痴呆的情况
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rhoda Au其他文献
Rhoda Au的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rhoda Au', 18)}}的其他基金
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测
- 批准号:
10625625 - 财政年份:2021
- 资助金额:
$ 652.63万 - 项目类别:
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment Supplement
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测:黑人
- 批准号:
10786286 - 财政年份:2021
- 资助金额:
$ 652.63万 - 项目类别:
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
弗雷明汉研究中用于阿尔茨海默病风险检测的精确大脑健康监测
- 批准号:
10214162 - 财政年份:2021
- 资助金额:
$ 652.63万 - 项目类别:
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
阿尔茨海默病高风险人群的认知异质性
- 批准号:
9975371 - 财政年份:2020
- 资助金额:
$ 652.63万 - 项目类别:
Cognitive Heterogeneity in those with high Alzheimer's Disease Risk
阿尔茨海默病高风险人群的认知异质性
- 批准号:
10404703 - 财政年份:2020
- 资助金额:
$ 652.63万 - 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
- 批准号:
10468279 - 财政年份:2020
- 资助金额:
$ 652.63万 - 项目类别:
Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia
弗雷明汉研究中的精确监测和评估:AD 的认知、MRI、遗传和生物标志物前体
- 批准号:
10256768 - 财政年份:2020
- 资助金额:
$ 652.63万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 652.63万 - 项目类别:
Operating Grants














{{item.name}}会员




